Nephrology and End-stage Renal Disease
Clinical research activity includes care for patients with end-stage renal disease, with attention to treatment decisions in advanced kidney failure and the management of patients receiving dialysis.
- Hemodialysis
- Renal replacement therapy
- Pre-transplant dialysis
Interest in kidney-related care extends to the interaction between immunosuppressive treatment and metabolic outcomes in dialysis populations.
ANCA-associated Vasculitis
The sponsor supports studies in ANCA vasculitis, with particular focus on patients who have progressed to renal failure and require ongoing management of autoimmune disease activity.
- Immunosuppression
- Autoimmune vasculitis
- Renal involvement
Research interest centers on treatment choices in complex vasculitis cases where kidney disease shapes long-term therapeutic strategy.
Metabolic Effects of Immunosuppressive Therapy
Trials examine how tacrolimus and related treatments influence carbohydrate metabolism in patients on hemodialysis, reflecting a focus on treatment-related metabolic changes.
- Glycemic profile
- Glucose metabolism
- Calcineurin inhibitor exposure
This area links kidney care with monitoring of metabolic tolerance in patients preparing for renal transplantation.
Colorectal and Proctologic Disease
Another area of interest is the treatment of hemorrhoidal disease, including procedural approaches aimed at relieving postoperative discomfort and improving local symptom control.
- Perianal infiltration
- Thermodestruction
- Radiofrequency treatment
Research in this domain reflects involvement in minimally invasive management of benign anorectal conditions.
